Literature DB >> 12413464

Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays.

Robert P Balog1, Y Emi Ponce de Souza, Hue M Tang, Gina M DeMasellis, Boning Gao, Adrian Avila, Desmond J Gaban, David Mittelman, John D Minna, Kevin J Luebke, Harold R Garner.   

Abstract

We have developed a method for the parallel analysis of multiple CpG sites in genomic DNA for their state of methylation. Hypermethylation of CpG islands within the promoters and 5' exons of genes has been found to be a mechanism of transcriptional inactivation associated with a variety of tumors. The method that we developed relies on the differential reactivity of methylated and unmethylated cytosines with sodium bisulfite, which exclusively converts unmethylated cytosines to deoxyuracils. The resulting sequence changes are determined with single-nucleotide resolution by hybridization to an oligonucleotide array. Cohybridization with a reference sample containing a different label provides an internal standard for assessment of methylation state. This method provides advantages in parallelism over existing methods of methylation analysis. We have demonstrated this technique with a region from the promoter of the tumor suppressor gene p16, which is hypermethylated in many cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413464      PMCID: PMC3484840          DOI: 10.1016/s0003-2697(02)00294-4

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  30 in total

Review 1.  X-chromosome inactivation and cell memory.

Authors:  A D Riggs; G P Pfeifer
Journal:  Trends Genet       Date:  1992-05       Impact factor: 11.639

Review 2.  Progress in understanding the molecular pathogenesis of human lung cancer.

Authors:  Y Sekido; K M Fong; J D Minna
Journal:  Biochim Biophys Acta       Date:  1998-08-19

3.  Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays.

Authors:  J G Hacia; B Sun; N Hunt; K Edgemon; D Mosbrook; C Robbins; S P Fodor; D A Tagle; F S Collins
Journal:  Genome Res       Date:  1998-12       Impact factor: 9.043

4.  Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

Authors:  M J Kozal; N Shah; N Shen; R Yang; R Fucini; T C Merigan; D D Richman; D Morris; E Hubbell; M Chee; T R Gingeras
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

5.  Thermodynamics and NMR of internal G.T mismatches in DNA.

Authors:  H T Allawi; J SantaLucia
Journal:  Biochemistry       Date:  1997-08-26       Impact factor: 3.162

6.  A paternal-specific methylation imprint marks the alleles of the mouse H19 gene.

Authors:  K D Tremblay; J R Saam; R S Ingram; S M Tilghman; M S Bartolomei
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

7.  Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.

Authors:  J R Melki; P C Vincent; S J Clark
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

8.  Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.

Authors:  G Deng; A Chen; J Hong; H S Chae; Y S Kim
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

9.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis.

Authors:  J G Hacia; L C Brody; M S Chee; S P Fodor; F S Collins
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

10.  5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

Authors:  A Merlo; J G Herman; L Mao; D J Lee; E Gabrielson; P C Burger; S B Baylin; D Sidransky
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

View more
  8 in total

1.  A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples.

Authors:  G Clément; J Benhattar
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

2.  Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.

Authors:  Yu-Wei Cheng; Carrie Shawber; Dan Notterman; Philip Paty; Francis Barany
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

Review 3.  Principles and challenges of genomewide DNA methylation analysis.

Authors:  Peter W Laird
Journal:  Nat Rev Genet       Date:  2010-03       Impact factor: 53.242

4.  Fabrication and characterization of DNA arrays prepared on carbon-on-metal substrates.

Authors:  Matthew R Lockett; Lloyd M Smith
Journal:  Anal Chem       Date:  2009-08-01       Impact factor: 6.986

Review 5.  The Role of DNA Methylation in Cardiovascular Risk and Disease: Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies.

Authors:  Jia Zhong; Golareh Agha; Andrea A Baccarelli
Journal:  Circ Res       Date:  2016-01-07       Impact factor: 17.367

Review 6.  DNA methylation methods: Global DNA methylation and methylomic analyses.

Authors:  Shizhao Li; Trygve O Tollefsbol
Journal:  Methods       Date:  2020-10-09       Impact factor: 3.608

7.  Microarray-based DNA methylation profiling: technology and applications.

Authors:  Axel Schumacher; Philipp Kapranov; Zachary Kaminsky; James Flanagan; Abbas Assadzadeh; Patrick Yau; Carl Virtanen; Neil Winegarden; Jill Cheng; Thomas Gingeras; Arturas Petronis
Journal:  Nucleic Acids Res       Date:  2006-01-20       Impact factor: 16.971

8.  Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.

Authors:  Sitharthan Kamalakaran; Jude Kendall; Xiaoyue Zhao; Chunlao Tang; Sohail Khan; Kandasamy Ravi; Theresa Auletta; Michael Riggs; Yun Wang; Aslaug Helland; Bjørn Naume; Nevenka Dimitrova; Anne-Lise Børresen-Dale; Jim Hicks; Robert Lucito
Journal:  Nucleic Acids Res       Date:  2009-05-27       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.